The European Union voted in favour of a UN General Assembly draft resolution on global health and foreign policy on 4 June 2026, while dissociating from references to technology transfer that it said must remain voluntary and on mutually agreed terms. The explanation of vote, delivered by Cyprus as Presidency of the Council of the EU, welcomed the resolution's focus on tackling social determinants of health as a critical step toward the 2030 Agenda, but stressed that technology transfer can only be undertaken on a voluntary basis and on mutually agreed terms, essential for an adequate and efficient response to future pandemics.
The EU also put on record that it can only recognise references to the World Trade Organization Doha Declaration on the TRIPS Agreement and Public Health that are fully aligned to its text, stating that no precedent is set with preambular paragraphs 33 to 35. Despite these reservations, the EU expressed full commitment to the overarching objective of the resolution and voted in favour, pledging to implement it.
The resolution, drafted by Brazil and a core group including France, Indonesia, Norway, Senegal, South Africa and Thailand, aims to accelerate the fight against diseases driven by social determinants of health. The EU reaffirmed its commitment to health sovereignty, with country ownership and responsibility at its core, and noted that the European Commission presented the Global Health Resilience Initiative the previous week, underscoring that global health remains a high priority for the EU.
Looking ahead, the EU said it looks forward to negotiations on two political declarations on HIV/AIDS and Pandemic Preparedness, Prevention and Response, which it said can make an important contribution to advancing better health for all.
Stakeholder impact
The EU's vote in favour, despite reservations, balances support for multilateral health initiatives with protection of intellectual property and technology transfer principles. For EU pharmaceutical and biotech companies, the insistence on voluntary technology transfer preserves commercial flexibility and innovation incentives, avoiding mandatory licensing that could affect profitability. For developing countries and global health NGOs, the resolution's focus on social determinants and universal health coverage is a positive step, though the caveats on technology transfer may limit access to essential medical technologies during pandemics. EU member states benefit from a unified position that reinforces their leadership in global health while safeguarding trade-related intellectual property rules. The resolution's implementation will require cross-sectoral policies and resilient health systems, potentially increasing demand for EU expertise and funding in partner countries.
← Atlas › News › Health & Lifestyle